Results 141 to 150 of about 65,639 (354)

Geographic and Socioeconomic Landscape of Veterans With Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background US Veterans experience higher rates and worse outcomes for head and neck squamous cell carcinoma (HNSCC) compared to civilians. Geographic and socioeconomic barriers remain unclear. Methods This retrospective descriptive study analyzed VA data nationwide (2012–2022), identifying Veterans with HNSCC using ICD codes. Subsites included
Kristen L. Zayan   +8 more
wiley   +1 more source

Overview of 100 patients with voice prosthesis after total laryngectomy--experience of single institution [Pregled 100 bolesnika sa govornom protezom nakon totalne laringektomije] [PDF]

open access: yes, 2012
Surgical procedures, especially total laryngectomy, used for treatment of advanced laryngeal carcinoma, have a profound adverse effect on the patient's physical, functional, and emotional health, and almost always decrease quality of life.
Bilić, Mario   +5 more
core  

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella   +12 more
wiley   +1 more source

Gore tex medialization thyroplasty- A case series [PDF]

open access: yes, 2012
Unilateral vocal fold paralysis classically presents with voice change, aspiration of ingested materials and cough. Medialization thyroplasty has become treatment of choice for un recovering vocal fold palsy.
Arjunan, Karthikeyan   +1 more
core   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon   +6 more
wiley   +1 more source

Pathophysiology in laryngeal granulomatous disease

open access: yes, 2020
A 35 year old male presented to our Pneumology Department with a one month history of persistent fever, moderate weight loss (7 kilograms in a week), night sweats, dysphagia, cough and a history of tobacco and alcohol use. Had notable hoarseness of voice and no history of recent tuberculosis contact. No cervical lymphadenopathy. Laboratory tests within
openaire   +1 more source

Home - About - Disclaimer - Privacy